Purchase Order 75A50322P00016

The Department of Health and Human Services Office of the Assistant Secretary for Preparedness and Response awarded a Firm Fixed Price Purchase Order contract to Emergent Biodefense Operations Lansing LLC for the WETVAX 2021 project. The contract has a potential value of $141,400.00 and a completion date of August 31, 2021. The contract does not have a set-aside designation. Emergent Biodefense Operations Lansing LLC is the prime contractor for this award, which is likely related to the agency's...

This federal contract was awarded by the Department of Health and Human Services (HHS) Office of the Assistant Secretary for Preparedness and Response to Emergent Biodefense Operations Lansing LLC for WETVAX POTENCY TESTING. The contract has a potential value of $136,612.00 and is a Firm Fixed Price Purchase Order. The place of performance is Canton, MA 02021, USA. The contract does not have a set-aside designation. As the awardee, Emergent Biodefense Operations Lansing LLC is a for-profit...

The Department of Health and Human Services Centers for Disease Control and Prevention awarded a Firm Fixed Price Purchase Order contract to Emergent Biodefense Operations Lansing LLC for vaccine potency testing services. The $127,526.00 contract has a completion date of November 30, 2018 and was awarded on August 31, 2018. The place of performance is Lansing, Michigan. Emergent Biodefense Operations Lansing LLC is a for-profit manufacturer. This contract was not set aside for any particular...

<p>The Department of Health and Human Services Centers for Disease Control and Prevention awarded a $121,618.00 firm fixed price purchase order to Sanofi Pasteur Biologics, LLC, a for-profit foreign-owned organization, for WETVAX testing services. The contract was awarded on May 11, 2017 with a completion date of September 30, 2017. The place of performance is Cambridge, MA 02139, USA. This contract was not set aside for any specific socioeconomic program.</p>

This federal contract, valued at $131,992.00, was awarded by the Department of Health and Human Services Office of the Assistant Secretary for Preparedness and Response to Emergent Biodefense Operations Lansing LLC, a for-profit limited liability company that manufactures goods. The contract is for the delivery of &quot;WET VAX SMALL POX&quot; and was awarded on a firm fixed-price basis on May 1, 2019, with a completion date of August 31, 2019. The contract does not have a set-aside designation....

This contract award, valued at $37,890,000, was issued by the Centers for Disease Control and Prevention (CDC) to Emergent BioDefense Operations Lansing LLC for the delivery of ACAM 2000 vaccines. ACAM 2000 is the only Food and Drug Administration (FDA)-licensed vaccine for the prevention of smallpox disease, a critical component of the U.S. government's strategic national stockpile. The contract, awarded on September 30, 2015, is a firm-fixed-price delivery order with an ultimate completion...

This is a firm fixed price delivery order awarded by the Department of Health and Human Services (HHS) Office of the Assistant Secretary for Preparedness and Response to Sanofi Pasteur Inc., a foreign-owned for-profit manufacturer of vaccines and pharmaceuticals. The order is for the storage of 7 bulk lots of H7N9 influenza vaccine at a cost of $129,360.00 over 12 months. The order was made under a larger $5.87 billion Indefinite Delivery Vehicle contract with HHS to supply medical...

This is a definitive contract awarded by the Department of Health and Human Services (HHS) Office of the Assistant Secretary for Preparedness and Response to Emergent Biodefense Operations Lansing LLC, a for-profit manufacturer of medical countermeasures. The $1,174,464,339.10 firm fixed-price contract is for the production of BioThrax, the only FDA-licensed vaccine for the prevention of anthrax disease, which is a critical component of the U.S. government's strategic national stockpile. The...

This is a firm fixed price delivery order awarded by the Office of the Assistant Secretary for Administration, a civilian federal agency, to Sanofi Pasteur Inc. to provide vaccines for stock. The contract has a ceiling value of $120,272.19 and a performance period ending on May 23, 2015. As the prime contractor, Sanofi Pasteur Inc. is a foreign-owned, for-profit manufacturer of goods that has received numerous awards from government agencies, including the Department of Veterans Affairs,...

This is a $748,857,151.46 firm fixed-price contract awarded by the U.S. Department of Health and Human Services (HHS) Office of the Assistant Secretary for Preparedness and Response to Emergent Product Development Gaithersburg Inc., a for-profit manufacturer, to develop and deliver the ACAM2000 smallpox (vaccinia) vaccine over a 10-year period. The contract was awarded on a sole-source basis as Emergent is the only FDA-licensed provider of ACAM2000. This contract does not have a set-aside...